Recruiting Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study NCT07257055 Conditions BTKi, Glofitamab, MCL, +2 more Locations MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
Recruiting Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children NCT06530004 Conditions Children, Efficacy, Female Urogenital Diseases, +8 more Locations First affiliated hospital of xiamen university — Xiamen, Fujian, China View Trial Details
Recruiting Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial NCT05734794 Conditions Nephrotic Syndrome in Children, Rituximab Locations Children's Hospital, Zhejiang University School of Medicine — Hangzhou, Zhejiang, China View Trial Details
